Docosahexanoic acid and ω-3 fatty acids in depression

Psychiatric Clinics of North America

Volumn 23, Issue 4, 2000, Pages 785-794

  Mischoulon, David ^b   Fava, Maurizio ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; KAVA; OMEGA 3 FATTY ACID; S ADENOSYLMETHIONINE;

ALCOHOL INTOXICATION; CLINICAL TRIAL; DEPRESSION; DIETARY INTAKE; DRUG EFFICACY; DRUG SAFETY; GEOGRAPHIC DISTRIBUTION; GINKGO BILOBA; HUMAN; HYPERICUM PERFORATUM; PRIORITY JOURNAL; REVIEW;

EID: 0034521499     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70197-0     Document Type: Article

References (60)

1. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression
2. Aetiology of multiple sclerosis
3. Effects of plasma membrane fluidity on serotonin transport by endothelial cells
4. Cognitive decline in the elderly: A double-blind, placebo-controlled multicenter study on efficacy of phosphatidyll-serine administration
5. Pharmacologic management of psychiatric illness during pregnancy and the postpartum period
6. Abnormal content of ω-6 and ω-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content
7. The polyenoic acids and their elongation products in the muscle tissue of Phacochoerus aethiopicus: A re-evaluation of "animal fat."
8. Linoleic acid and linolenic acid elongation products in muscle tissue of Sncerus caffer and other ruminant species
9. The changing rate of major depression: Cross national comparisons
10. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients
11. Docosahexaenoic acid (22:6ω3)-induced relaxation of the rat aorta
12. Infant cerebral cortex and dietary fatty acids
13. Infant cerebral cortex phospholipid fatty-acid composition and diet
14. Effect of diet on infant subcutaneous tissue triglyceride fatty acids
15. Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex
16. Age- and dietary-related distributions of hepatic arachidonic and docosahexaenoic acid in early infancy
17. New approaches to the treatment of refractory depression
18. Definition and epidemiology of treatment-resistant depression
19. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
20. The effect of docosahexanoic acid on aggression in young adults: A double-blind study
21. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics
22. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy
23. Risks of cholesterol-lowering therapies
24. Do plasma polyunsaturates predict hostility and depression?
25. A replication study of violent and nonviolent subjects: Cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids
26. Deficiencies in polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis
27. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation
28. Dietary fat intake and the risk of incident dementia in the Rotterdam study
29. The effects of fat and cholesterol on social behavior in monkeys
30. Fatty acids and schizophrenia
31. Effect of dietary fat and cholesterol supplements on glucagon receptor binding and adenylate cyclase activity of rat liver plasma membrane
32. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients
33. Fatty acids, cytokines, and major depression
34. Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20: 5 omega 3 ratio in cholesteryl esters and phospholipids
35. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders
36. Schizophrenic symptoms and dietary intake of ω-3 fatty acids
37. Herbal remedies for mental illness
38. The use of natural medications in psychiatry: A commentary
39. Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis
40. Alzheimer's disease and omega-3 fatty acids: Hypothesis
41. Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation
42. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients
43. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients
44. Omega-3 fatty acids in the US food supply
45. Docosahexanoic acid: Membrane function and metabolism
46. The effects of ethanol on polyunsaturated fatty acid composition
47. Are omega 3 fatty acids essential nutrients for mammals?
48. The modulation of protein kinase C activity by membrane lipid bilayer structure
49. S-adenosylmethionine (Ademethionine) in psychiatric disorders: Historical perspective and current status
50. Nutritional properties of fish oils
51. Omega 3 fatty acids in bipolar disorder
52. Effect of chronic ethanol administration on phospholipid acyl groups of synaptic plasma membrane fraction isolated from guinea pig brain
53. Nutritional role of omega-3 fatty acids during the perinatal period
54. Mortality, cardiovascular risk factors, and diet in China, Finland and the United States
55. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. The Family Heart Study
56. The treatment of depressive symptoms secondary to alcoholism, opiate addiction and schizophrenia: Evidence for the efficacy of tricyclics
57. Platelet membrane fluidity of Alzheimer's disease and major depression